Quick Answer
Cytosorbents Corp reported Cash And Cash Equivalents At Carrying Value of $6.25 million for the year ending 2025.
- Cytosorbents Corp showed an increase of +90.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Cytosorbents Corp's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), Cytosorbents Corp's Cash And Cash Equivalents At Carrying Value has grown by 291.6%.
- Historical annual values: Fiscal year 2025: $6.25 million | Fiscal year 2024: $3.28 million | Fiscal year 2023: $14.13 million | Fiscal year 2022: $22.14 million | Fiscal year 2021: $52.14 million | Fiscal year 2020: $71.42 million | Fiscal year 2019: $12.23 million | Fiscal year 2018: $22.37 million | Fiscal year 2017: $17.32 million | Fiscal year 2016: $5.25 million | Fiscal year 2015: $5.32 million | Fiscal year 2014: $3.61 million | Fiscal year 2013: $2.18 million | Fiscal year 2012: $1.73 million | Fiscal year 2011: $1.19 million | Fiscal year 2010: $1.06 million | Fiscal year 2009: $1.60 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: